Pharma Novartis lays off 64 workers in Dorval

Novartis pharma lays off 64 workers in Dorval


Swiss giant Novartis is cutting 64 jobs at its Dorval facilities as part of a restructuring that began last April, including more than 30 today, Le Journal learned.  

“This restructuring will affect approximately 7 employees (as of October 14, 2022), 21 employees (as of October 28, 2022) and 36 employees (as of November 4, 2022)”, confirmed to the Journal Claudja Joseph, manager Principal, Associate Engagement and Novartis External.

“This will allow us to reduce duplication of organizational structures and create a leaner, learning organization, improving patient and customer orientation,” she added.

Fair” Treatment

Novartis integrates Pharma and Oncology business units into one and even Innovative Medicines (IM) division to serve its markets.

Without providing details, Novartis assures that she will do everything to help affected employees find new employment within the company or outside.

“We recognize the impact that these changes will have on our staff and will ensure that all the partners concerned in a fair and transparent way, in particular by helping them to find a new job internally or externally”, concludes Claudja Joseph from Novartis.

You have any scoop to send us?

Do you have something to tell us about this story?

Do you have a scoop that our readers might be interested in?

Email us at or call us directly at 1 800-63SCOOP.